Laertis Ikonomou, PhD
Chair (August 2019-June 2021)

University at Buffalo, The State University of New York
Buffalo, NY, United States

[1] L. Ikonomou, R.J. Freishtat, D.E. Wagner, A. Panoskaltsis-Mortari, D.J. Weiss, The Global Emergence of Unregulated Stem Cell Treatments for Respiratory Diseases Professional Societies Need to Act, Ann Am Thorac Soc. 13(8) (2016) 1205-1207.

[2] D.E. Wagner, L. Turner, A. Panoskaltsis-Mortari, D.J. Weiss, L. Ikonomou, Co-opting of ClinicalTrials.gov by patient-funded studies, Lancet Resp. Med. 6(8) (2018) 579-581.
[3] D.J. Weiss, L. Turner, A.D. Levine, L. Ikonomou, Medical societies, patient education initiatives, public debate and marketing of unproven stem cell interventions, Cytotherapy 20(2) (2018) 165-168.
[4] L. Ikonomou, A.D. Levine, P. Hematti, B.L. Levine, Cell Banking for Cell and Gene Therapy-Regulatory, Ethical, and Scientific Considerations., Bioprocess Int. 19((6)i) (2021) 10-13.
[5] L. Turner, M. Munsie, A.D. Levine, L. Ikonomou, Ethical issues and public communication in the development of cell-based treatments for COVID-19: Lessons from the pandemic, Stem Cell Rep. 16(11) (2021) 2567-2576.